Lv5
920 积分 2023-08-10 加入
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients
1天前
待确认
Clotting factors: Clinical biochemistry and their roles as plasma enzymes
2个月前
已完结
Inhibition of Adhesion, Invasion, and Metastasis by Antibodies Targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)
2个月前
已完结
Anti-EGFR Agents: Current Status, Forecasts and Future Directions
2个月前
已完结
RETRACTED: The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility
2个月前
已完结
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy
3个月前
已完结
A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
3个月前
已完结
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
3个月前
已完结
USP1 inhibition: A journey from target discovery to clinical translation
3个月前
已完结
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114
4个月前
已完结
皖公网安备34019202002308
